Equilibrium offers advanced TMS therapy — a clinically proven, non-invasive treatment for depression, anxiety, OCD, PTSD, and more. No medication required. Real, lasting results.
What is TMS
Transcranial Magnetic Stimulation (TMS) is a non-invasive, FDA-approved treatment that uses targeted magnetic pulses to stimulate specific areas of the brain. Delivered through a coil placed gently on the scalp, these painless pulses help regulate neural activity in regions involved in mood, thought patterns, and other functions. Unlike medications, TMS works directly on the brain’s circuitry to promote neuroplasticity—essentially helping the brain form healthier connections—without the need for surgery, anesthesia, or systemic side effects. Sessions are typically outpatient, lasting 20–40 minutes, and patients remain fully awake and can drive themselves home afterward.
What is Is'nt
TMS is not electroconvulsive therapy (ECT or “shock therapy”), nor does it involve any electrical shocks, seizures, or memory loss. It is also not a medication, invasive procedure, or experimental treatment—it's a well-studied, office-based therapy with a strong safety profile. TMS does not require hospitalization, sedation, or downtime, and it is not intended as a first-line option for everyone; it's particularly helpful for those who haven't achieved full relief from traditional treatments like antidepressants or talk therapy. Most importantly, it's a precise, localized brain stimulation—not a blanket “mind-altering” or permanent change to your personality.
Major Depressive Disorder and Treatment-Resistant Depression are the most well-studied TMS indications. TMS stimulates the left dorsolateral prefrontal cortex to reactivate underactive mood-regulating circuits.
50-60% response rate • 30-35% full remission in TRD patients
Generalized anxiety, panic disorder, and anxious depression respond to TMS protocols targeting overactive fear-processing regions, calming hyperarousal and reducing chronic anxiety without sedating medications.
FDA-cleared for anxious depression • Significant GAD-7 score reductions
Emerging research supports TMS for anorexia nervosa and binge-eating disorder by modulating food-reward circuitry and reducing compulsive thought patterns tied to disordered eating behaviors.
Off-label protocol • Targets prefrontal & reward pathways
TMS is used adjunctively for bipolar depression, offering a nonpharmacological option during depressive episodes with careful protocol selection to avoid mood destabilization.
Off-label • Adjunct to mood stabilizers • Reduces depressive episodes
Non-invasive - no surgery, no anesthesia required
Off-label protocols for neurological conditions
Patients resume normal activities immediately after treatment
Parkinson's Disease
Parkinson's patients experience motor and cognitive decline as dopaminergic pathways degrade. TMS targets the motor cortex and supplementary motor area to reduce tremors, improve motor function, and address associated depression.
TMS Protocol Focus
High-frequency rTMS over the motor cortex
Adjunct to Deep Brain Stimulation
adjustment • Targets motor planning circuits
Concussion & TBI Recovery
Post-concussion syndrome and traumatic brain injury leave patients with persistent cognitive fog, mood dysregulation, and headaches. TMS supports neural repair by promoting neuroplasticity and restoring disrupted connectivity.
TMS Protocol Focus
Targets prefrontal cortex and default mode network Addresses post-concussion depression and cognitive symptoms Promotes neuroplastic recovery
Dementia & Cognative Decline
Early to moderate dementia patients can benefit from TMS through stimulation of memory-related circuits. Research supports improvements in cognitive function, quality of life, and reduced behavioral symptoms.
TMS Protocol Focus
Targets dorsolateral PFC and parietal regions
Deep TMS (dTMS) protocols for Alzheimer's Improves memory encoding and executive function
Breakthrough Treatment Without a Single Pill
Transcranial Magnetic Stimulation (TMS) uses precisely targeted magnetic pulses to activate underperforming areas of the brain linked to depression, anxiety, and other mental health conditions.
Unlike medication, TMS works directly at the neurological source — stimulating brain circuits to restore healthy activity patterns. It is non-invasive, requires no anesthesia, and patients resume normal life immediately after each session.
No systemic side effects from medication
Outpatient - sessions fit into your workday
Proven effective after medication failure
No memory loss, no anesthesia, no downtime
1 Day TMS
A one-day intensive TMS protocol condenses multiple sessions into a single extended visit (typically 9–10 hours), providing rapid symptom relief for those seeking the fastest turnaround with minimal disruption to work or travel.
3 Day TMS
A three-day accelerated course strikes a balance by delivering concentrated treatments over a short period, often yielding noticeable improvements within days while remaining highly convenient.
5 Day TMS
Traditional five-day-per-week schedule (spread over 4–6 weeks) remains a proven standard, allowing gradual, sustained brain changes with excellent long-term durability and high response rates for most patients. All options are non-invasive, well-tolerated, and effective, with accelerated formats particularly beneficial for treatment-resistant depression when quicker results are desired.
Maintenance
After completing an initial course of TMS, many patients benefit from ongoing maintenance sessions to sustain their improvements and prevent symptom relapse. Maintenance typically involves less frequent treatments—such as one or two sessions per week or periodic booster courses every few months—tailored to the individual’s response and needs.
"I've tried many options over the years and I am so glad I found TMS treatment for my son's depression. A real gamer changer!"
- Cheryl A Colleyville TX.
1 in 5
Americans experience a mental health disorder each year -many with no effective long-term treatment
6.9 Million
Americans living with Parkinson's, Alzheimer's, or TBI -growing demand for neuromodulation therapies
30-40%
Of depression patients are treatment-resistant, exhausting pharmaceutical options